OLANZAPINE ODT TEVA ® 5 MG

Country: Ísrael

Tungumál: enska

Heimild: Ministry of Health

Virkt innihaldsefni:

OLANZAPINE 5 MG

Fáanlegur frá:

SALOMON,LEVIN & ELSTEIN LTD

ATC númer:

N05AH03

Lyfjaform:

TABLETS ORODISPERSIBLE

Stjórnsýsluleið:

PER OS

Framleitt af:

TEVA OPERATIONS POLAND SP.ZO.O

Meðferðarhópur:

OLANZAPINE

Ábendingar:

Acute and maintenance treatment of schizophrenia. Olanzapine ODT Teva is indicated for the management of the manifestations of psychotic disorders. Olanzapine ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanzapine ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanzapine ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Leyfisdagur:

2011-05-01